Transfection Sample Clauses

Transfection. Lipofectamine 2000 (Invitrogen) was used to transfect DNA plasmids and LNA- RNA into Neuro2A cells. Magnetofection using Neuromag (OZBioscience) was used to transfect xxXXX inhibitors into primary cultured neurons according to according to manufacturer's instructions. Fluorescence in situ hybridization for miRNAs on brain sections and cells. Mature hippocampal neurons or brains from p21 mice were used for in situ hybridization as described previously (Xxxxxxxxxxx et al., 2011) Western blot analysis Western blot analysis was performed as described before (Xxxxx et al., 2010). Rabbit anti-Kv4.2 antibodies were used at 1:1000 (Millipore); mouse anti-GluN1 antibodies were used at 1:1000 (BD Pharmingen); and mouse anti α-tubulin (Sigma) antibodies wer used at 1:1,000, 000. Specific signals were detected with horseradish- peroxidase-coupled secondary antibodies (GE Healthcare) and Enhanced ChemiLuminescence (Thermo Scientific). Biotinylation assay High density cortical neurons were used at 14-18 DIV to perform biotinylation assay. Cells were incubated with 1.0 mg/ml EZ-Link sulfo-NHS-Biotin (Thermo Scientific) in 1X PBS (Hyclone) for 30 min at 4°C. Cell lysates were prepared and biotinylated proteins were pulled down as decribed previously (Xxxxxx, 2000). Western blot analysis was used to assess the specific protein levels (Xxxxx et al., 2011). Dual-luciferase assay Neuro2A cells were used to perform the luciferase assays and luciferase activity was measured by dual luciferase assay using Renilla and Firefly luciferase according to the manufacturer’s protocol (Promega). Statistics. All statistical analyses were performed in SPSS 17.0 and PASW Statistics 18. Data were tested for normality and homogeneity of variances, and appropriate tests were used as indicated for each figure Results Kv4.2 mRNA is a putative target of miR-324-5p
AutoNDA by SimpleDocs
Transfection. HepG2 cells were seeded into six p100 dishes. XGtremeGENE 9 DNA Transfection Reagent (Roche) was mixed with serum free media, and same amount of Vector and MTSGCore plasmid DNAs were each added to two sets of transfection reagent, at two ratios of transfection reagent to plasmid DNA (3:1 and 6:1). Incubated transfection complexes were added to the cells in a dropwise manner, and after incubation and switching to media containing G418, the cells were split into new p100 dishes at a dilution of 1:50. Cell Culture and Plasmid DNA Verification. Cells were trypsinized once a week and media were changed every other day. At the time cell colonies were visible, big colonies were selected using cloning cylinders, trypsinized, and added to G418 media in 6Gwell plates for better growth. After 2 weeks of growth, DNA was isolated from samples of the transfected cells using DNA lysis buffer and ethanol precipitation, and the plasmid taken up by the cells was verified by PCR using primers specifically designed for each insert. SDSHPAGE, Western Blotting, and Protein Detection. Cells with pCMV vector and cells with MTSGCore clones were each lysed using RIPA buffer (SigmaGAldrich) to obtain the nuclear and mitochondrial fractions. Protein concentration of each sample was determined by Bradford Protein Assay. Following a standard western blot protocol, 20 μg of each sample were run on a preGmade polyacrylamide gel, electrophoretically transferred to a membrane, and incubated overnight in a blocking solution of 5% nonGfat dried milk and 0.1% Tween 20. Primary and secondary antiGSHDB (mitochondrial marker, Novus Biologicals, dilution of 1:5000) and antiGHA antibodies (MTSGCore marker, Thermo Scientific, dilution of 1:500) were added, and West Pico Chemiluminescent Substrate (Thermo Scientific) was used for protein detection. The membrane was exposed for 15 minutes on a film.
Transfection. For all transfections, cells were plated in 6-wells plates and grown over-night to a 30% confluency with mostly single cells. Cells were incubated with 15 (g DNA con- struct, for 2 days using Fugene6TM transfection reagent (Boehringer) according to the manufacturer’s recommendations. The pInd/pVgRXR transfected clones were selected by neomycin (G418, Gibco BRL), the pTracer transfected cells were not selected, but traced with GFP. To enhance transcription of the construct in the pInd/pVgRXR system, 25 μM MuristeroneA (MuA) was added 72 hours prior to experiments. Detergent extractions, cell lysis, and Western blot analysis Cells were grown to 75% density, left on ice for 10 minutes and rinsed with ice- cold PBS/1mM CaCl2 /1mM MgCl2. For extraction, cells were incubated with 0.5% Triton-X-100 in extraction buffer (50 mM TrisHCl, pH7.4, 100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 300 mM sucrose, 1 tablet complete protease inhibitor (Boehringer Mannheim), gently scraped from the dish, collected and rotated for 30 minutes at 4˚C. The samples were collected and spun down (15 minutes, 15000 rpm). The detergent insoluble fraction (pellet) was separated from the supernatant and further lysed in 100°C SDS buffer (1% SDS, 10 mM EDTA, 10 mM TrisHCl pH7.4, 1 tablet complete protease inhibitor). For total protein lysate, cells were lysed in hot-SDS buffer immedia- tely after rinzing. Protein concentrations in lysates were measured using Bio-Rad DC Protein Assay (Bio-Rad Lab., Hercules, CA), for equalized loading of the individual samples. Lysates were size fractionated by SDS/PAGE and semi-dry blotted onto polyv- inyl difluoride membrane (Millipore, Bedford, MA). Filters were blocked for 1 hour in 5% skim milk, incubated with a primary antibody for two hours, washed in PBS/ 0.05% Tween-20, and incubated for 1 hour with an anti-mouse IgG HRP-conjugate (Transduction Laboratories, Lexington, KY). The filter was developed with ECL detecti- on substrate (Amersham Pharmacia Biotech, Buckinghamshire, UK). Immunofluorescence Microscopy Cell cultures transfected with the pIND vector were incubated 72 hours with 25 μM MuA to induce transcription. Then they were rinsed with ice-cold PBS / 1mM CaCl2/1mM MgCl2 and fixed with either cold methanol (15 minutes, -20°C) or 4% paraformaldehyd (as previously described; Balzar et al., 1999b) and air-dried. Fixed cells were re-hydrated with PBS, blocked with 5% skim milk in PBS, incubated with a primary antibody for 2 hours, followed by 1 hour inc...
Transfection. To verify the effects of xxXXX-302 family on MSC fate decisions, xxXXX inhibitors were introduced into the cells to decrease xxXXX expression level (Xxxxxxxx, Xxxxx et al. 2012). Subsequently specific xxXXX mimics were also used to simulate over expression of xxXXX-302 family members. The phenotypical consequences of transfection of either of inhibitor or mimic were investigated after treatment with differentiation media. Having opted for non-virally induced transfection, lipofection and electroporation were performed as two compared methods of xxXXX transfection into MSCs and then the experiment followed by transfecting xxXXX inhibitor or mimic via lipofection.

Related to Transfection

  • Transfer of Materials In the event Acceleron exercises its rights pursuant to Section 10.5.1, Celgene shall negotiate in good faith with Acceleron regarding Celgene transferring to Acceleron, at Acceleron’s cost, materials developed under this Agreement in the course of Developing and Commercializing Licensed Compounds or Licensed Products that are directly related to Licensed Compounds or Licensed Products to the extent provided in and in accordance with such agreement.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Storage of Materials Borrower shall cause all materials supplied for or intended to be utilized in the construction of the Improvements but not affixed to or incorporated into the Property to be stored on the Property or at such other location as may be approved by Lender in writing, with adequate safeguards to prevent loss, theft, damage or commingling with other materials not intended to be utilized in the construction of the Improvements.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • GARBAGE DISPOSAL, RECYCLING, AND BIODEGRADABLE MATERIALS A. Concessionaire shall be responsible for maintaining the cleanliness of the Concession Premises. Concessionaire shall ensure placement of all garbage and trash generated by the Concession Operation in designated containers and that said containers are emptied daily, or as more frequently required by Department, at a location within the Area designated by Department. Disposal costs from this latter location shall be borne by Department. Concessionaire shall provide such additional trash containers as may be required to keep the immediate Concession Premises clean at all times. The type of trash containers provided by Concessionaire shall be approved by Department prior to use.

  • DELIVERY, STORAGE, AND HANDLING The Contractor shall be responsible to inspect all components on delivery to ensure that no damage occurred during shipping or handling for furnish and installation projects. For equipment only purchases, the ordering entity shall be responsible to inspect all components on delivery. Materials must be stored in original undamaged packaging in such a manner to ensure proper ventilation and drainage, and to protect against damage, weather, vandalism, and theft until ready for installation.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Removal of Materials If you decide you would like to remove your Materials from the Service, you may provide written notice to Prime Publishing by either deleting the image through the Prime Publishing interface or by contacting Prime Publishing customer service, and Prime Publishing will remove such Materials from the Service within a reasonable period of time. 5) License for Name, Trademarks and Likenesses. You hereby grant to Prime Publishing, its Affiliates and sublicensees a nonexclusive, worldwide, royalty-free license to use all trademarks, trade names, and the names and likenesses of any individuals that appear in the Materials. You grant Prime Publishing, its Affiliates and sublicensees the right to use the name that you submit in connection with the Materials. 6) Specifications and Guidelines. You agree to submit Materials to us in accordance with all guidelines for use of the Service posted on the Prime Publishing web site or of which you are otherwise notified ("Guidelines"), as these Guidelines may be changed in the future. 7)

  • Marking Shipments, shipping containers and palletized unit loads shall be marked in accordance with MIL- STD-129R with Change 1 dated 24 May 2018.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

Time is Money Join Law Insider Premium to draft better contracts faster.